#Asia Pacific Virus Safety Testing Services Market | Explore Tumblr posts and blogs

abhilashnale · 21 days ago

Text

Colorectal Cancer Screening Market Global Insights: Business Demand, Top Leading Players, and Precise Outlook with Future Scope, Forecast by 2032

The Evolutionary Path of the Colorectal Cancer Screening Market

The global Colorectal Cancer Screening market has emerged as a focal point for businesses, offering a plethora of opportunities and challenges. As industries navigate this landscape, understanding its evolution becomes crucial for strategic planning and decision-making.

According to Straits Research, the global colorectal cancer screening market size was valued at USD 13734.03 Million in 2022. It is projected to reach from USD XX Million in 2023 to USD 26441.8 Million by 2031, growing at a CAGR of 7.55% during the forecast period (2023–2031).

Historically, the Colorectal Cancer Screening market has witnessed significant transformations, driven by technological innovations, regulatory changes, and shifting consumer preferences. These shifts have not only reshaped the market landscape but also presented businesses with new avenues for growth and innovation.

Note: We're in the process of updating our reports. If you're seeking updated primary and secondary data from 2023-2031, coupled with insights on Cost Module, Business Strategy, and Competitive Landscape, kindly click ""request free sample report."" The comprehensive report will reach you via email within 24 to 48 hours.

Get Access to a Free Copy of Our Latest Sample Report@https://straitsresearch.com/report/colorectal-cancer-screening-market/request-sample

Companies and Manufacturers Covered:

Key market players play a pivotal role in shaping the market narrative. By profiling industry leaders and their strategic initiatives, the report offers insights into competitive dynamics and market trends. These insights are invaluable for businesses seeking to gain a competitive edge and capitalize on emerging opportunities.

Clinical Genomics Technologies Pty Ltd

Epigenomics AG

Exact Sciences Corporation

Hemosure Inc

Novigenix SA

Quidel Corporation

Siemens Healthcare Private Limited

Sysmex Corporation

Eiken Chemical Co. Ltd

Polymedco Inc

Olympus Corporation

A recent market analysis provides a comprehensive overview of the Global Colorectal Cancer Screening Market, highlighting key growth drivers and emerging trends. This report serves as a valuable resource for businesses, offering insights into the market dynamics, competitive landscape, and growth prospects.

Buy this Premium Research Report@https://straitsresearch.com/buy-now/colorectal-cancer-screening-market

The quantitative analysis accompanying the report offers a decade-long perspective on the market's trajectory. By examining historical data and forecasting future trends, stakeholders can gain a deeper understanding of market dynamics and make informed decisions.

Global Regional Outlook:

North America: North America is currently the largest market for Colorectal Cancer Screening, accounting for a significant share of the global market.

Asia Pacific: While the North America leads in market size, Asia Pacific is emerging as the fastest growing region in the Colorectal Cancer Screening market.

Research Methodology

The research methodology employed in curating this report is rigorous and comprehensive. By leveraging both primary and secondary data sources, the report ensures accuracy and reliability. Through interviews with industry experts, analysis of annual reports, and examination of Colorectal Cancer Screening market trends, the report offers a holistic view of the market landscape.

Market Segmentation:

By Screening Tests

Stool-Based Tests

Colonoscopy

Ct Colonography (Virtual Colonoscopy)

Flexible Sigmoidoscopy

By End-User

Hospitals

Independent Diagnostic Labs

Ask Here For More Customization Study@https://straitsresearch.com/report/colorectal-cancer-screening-market/toc

Report Features:

Actionable market intelligence for strategic decision-making

Comprehensive forecasts spanning 2018 - 2031

In-depth growth trend assessments

Segment-specific and regional revenue projections

Competitive analysis and market share insights

Innovative product listings for competitive advantage

Insights into the market implications of COVID-19

Report availability in various formats: PDF, XLS, PPT, and digital dashboards

In conclusion, the global Colorectal Cancer Screening market offers a dynamic and evolving landscape for businesses. By staying abreast of market trends, leveraging data-driven insights, and adopting a strategic approach, businesses can navigate this landscape successfully and drive growth.

Report Customization:

Our report is adaptable to your specific needs. For tailored insights, please reach out to our sales team at [email protected]. Additionally, you can contact our representatives directly at +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.) to discuss your research criteria.

0 notes

marketanalysisdata · 3 hours ago

Text

In Vitro Diagnostics Industry Research Report 2030 By Players, Regions, Types & Applications

The global in vitro diagnostics (IVD) market, valued at an estimated USD 80.71 billion in 2024, is anticipated to grow at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2030. This projected growth is largely driven by the increasing utilization of IVD tools and technologies, a response to the rising incidence of both infectious and chronic diseases globally. The development and implementation of automated IVD systems in laboratories and hospitals further contribute to this expansion, offering healthcare providers tools to make diagnoses that are efficient, precise, and free from errors. Additionally, the continual launch of new IVD products by leading companies plays a significant role in fueling this market’s growth.

A noteworthy example of this innovation in IVD products is seen in ELITechGroup’s recent expansion of its diagnostic portfolio. In January 2024, ELITechGroup introduced the GI Bacterial PLUS ELITe MGB Kit, which received CE-IVDR certification. This product marks the beginning of the company’s Gastrointestinal (GI) assay panel and is designed to detect bacterial pathogens responsible for GI infections. ELITechGroup’s expansion plans include three more kits for launch within the next quarter, covering a broader spectrum of gastrointestinal infections. These new products aim to equip laboratories and healthcare professionals with advanced tools for precise diagnosis and improved management of GI conditions.

Gather more insights about the market drivers, restrains and growth of the In Vitro Diagnostics Market

Regional Insights:

North America In Vitro Diagnostics Market:

The North American in vitro diagnostics (IVD) market led the global sector in 2024, holding a 42.28% share. The region is expected to maintain its dominance throughout the forecast period, largely driven by several key factors, including the growing prevalence of chronic diseases, the presence of established IVD companies, the frequent introduction of innovative diagnostic tests, and strong government funding support. For example, in January 2023, BD and CerTest Biotec obtained an Emergency Use Authorization (EUA) from the U.S. FDA for a PCR test to detect the Mpox virus, highlighting regulatory support for advanced diagnostics. The increasing demand for genetic testing, particularly for personalized treatments in diabetes and cancer, is further expected to support the growth of the IVD market in North America.

Europe In Vitro Diagnostics Market Trends:

The European IVD market is growing, driven by an emphasis on infectious disease testing, molecular diagnostics, and adherence to regulatory requirements like CE-IVDR. Following the COVID-19 pandemic, demand for infectious disease diagnostics surged, with companies like Siemens Healthineers introducing platforms such as the Atellica CI Analyzer for efficient testing. The molecular diagnostics sector is also expanding, with ELITechGroup’s CE-IVDR-certified GI Bacterial PLUS kit as a recent example, aimed at detecting gastrointestinal infections. Stringent IVDR standards in Europe foster innovation, improving diagnostic accuracy and safety across the continent.

Asia Pacific In Vitro Diagnostics Market Trends:

The Asia Pacific IVD market is projected to experience significant growth, with a CAGR of 8.59% over the forecast period. Key drivers include stabilizing economies, a rapidly growing middle class, supportive government policies, and rapid urbanization. For instance, in October 2023, Fapon partnered with Halodoc to boost IVD product sales and services in Indonesia. Major IVD players are also collaborating with regional partners to expand their reach in developing countries across Asia Pacific.

The Chinese IVD market is growing rapidly, fueled by rising demand for molecular diagnostics, point-of-care testing, and digital health integration. Molecular diagnostics are particularly in demand for infectious diseases and oncology, supported by public health initiatives and increased healthcare spending.

Japan’s IVD market growth is driven by an aging population and progress in personalized medicine. Key trends include a growing use of molecular diagnostics for oncology and genetic testing, which aid in identifying targeted treatments for age-related diseases

Latin America In Vitro Diagnostics Market Trends:

The IVD market in Latin America is expanding due to increased healthcare investments, a focus on disease prevention, and enhanced healthcare access. A prominent trend is the adoption of point-of-care testing for infectious diseases like dengue, Zika, and COVID-19, especially in remote areas. Demand for molecular diagnostics in oncology is also growing as awareness of personalized medicine rises. Public-private partnerships and government initiatives are building diagnostics infrastructure, making advanced testing technologies more accessible across the region.

Middle East & Africa In Vitro Diagnostics Market Trends:

The IVD market in the Middle East and Africa (MEA) is set for growth, driven by increased healthcare spending and the prevalence of infectious diseases. Major trends include the adoption of advanced molecular diagnostics and point-of-care testing to improve disease detection and management. Additionally, a focus on personalized medicine and government initiatives aimed at enhancing healthcare infrastructure are supporting market expansion. Collaborations between local and international players are fostering innovation, making diagnostic solutions more accessible across the region.

Browse through Grand View Research's Category Clinical Diagnostics Industry Research Reports.

The global saliva collection and diagnostics market size was estimated at USD 818.9 million in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030.

The global cholesterol testing products and services market size was estimated at USD 19.85 billion in 2024 and is projected to grow at a CAGR of 8.4% from 2025 to 2030.

Key Companies & Market Share Insights:

Among the prominent players in the IVD market are F. Hoffmann-La Roche Ltd., Abbott, Quest Diagnostics Incorporated, and Danaher. These companies actively pursue strategies like new product launches, mergers and acquisitions, and partnerships to strengthen and diversify their product offerings. These efforts are focused on expanding their product portfolios, introducing technologically advanced and innovative diagnostic tools, and improving their competitive positioning within the market.

Emerging companies in the IVD sector, including Llusern Scientific, Biocartis Group NV, ARUP Laboratories, Veracyte, and Exact Sciences Corp, are also making strides. These companies concentrate on developing novel and accurate IVD testing products, contributing to overall healthcare improvements. They frequently collaborate with research institutions, governmental bodies, and global leaders to expand their product reach and presence in new, high-potential markets.

Order a free sample PDF of the In Vitro Diagnostics Market Intelligence Study, published by Grand View Research.

#In Vitro Diagnostics Market Share #In Vitro Diagnostics Market Analysis

0 notes

marketstudyreport · 3 hours ago

Text

In Vitro Diagnostics Market 2030 Outlook by Growth Rate, Trends, Size and Opportunities

Gather more insights about the market drivers, restrains and growth of the In Vitro Diagnostics Market

Regional Insights:

North America In Vitro Diagnostics Market:

Europe In Vitro Diagnostics Market Trends:

Asia Pacific In Vitro Diagnostics Market Trends:

Latin America In Vitro Diagnostics Market Trends:

Middle East & Africa In Vitro Diagnostics Market Trends:

Browse through Grand View Research's Category Clinical Diagnostics Industry Research Reports.

The global saliva collection and diagnostics market size was estimated at USD 818.9 million in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030.

The global cholesterol testing products and services market size was estimated at USD 19.85 billion in 2024 and is projected to grow at a CAGR of 8.4% from 2025 to 2030.

Key Companies & Market Share Insights:

Order a free sample PDF of the In Vitro Diagnostics Market Intelligence Study, published by Grand View Research.

#In Vitro Diagnostics Market Share #In Vitro Diagnostics Market Analysis

0 notes

wellnessweb · 5 months ago

Text

Healthcare Analytical Testing Services Market Size: Trends & Insights

The Healthcare Analytical Testing Services Market Size was valued at USD 14.1 billion in 2023, and is expected to reach USD 26.88 billion by 2031, and grow at a CAGR of 8.4% over the forecast period 2024-2031.Healthcare Analytical Testing Services (HATS) play a crucial role in ensuring the safety, efficacy, and quality of medical products and treatments. These services encompass a wide range of activities, including chemical analysis, microbiological testing, and clinical trial support, to validate and verify the integrity of pharmaceuticals, medical devices, and biologics. By employing advanced technologies and methodologies, HATS providers help healthcare companies comply with regulatory standards, mitigate risks, and bring innovative solutions to market faster. Their expertise not only supports product development but also enhances patient safety and public health outcomes, making them an indispensable part of the healthcare ecosystem.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/1048

The Healthcare Analytical Testing Services Market report contains in-depth analyses of the value chain and market distributors. The market analysis also covers a number of crucial factors that have a big impact on market growth. The report also includes a statistical analysis that identifies and lists the numerous market-influencing and market-restraining variables. With the use of market scenarios, the research report's scope is broadened to include a comparison of the top service providers, their profits, and the prices of significant market segments.

COVID-19 Impact Analysis

Fewer items have been shipped globally overall as a result of the corona virus outbreak. The raw material supply, which is essential for the sector's sustainability, has also been impacted by this. This study on the Healthcare Analytical Testing Services Market offers a thorough analysis of market shipping production throughout the course of the forecast period, together with observations of noteworthy changes over time.

Market Segmentation

By Type

Raw Material Testing Services

Bioanalytical testing services

Physical Characterization Services

Batch-release Testing Services

Environmental Monitoring Services

Microbial Testing

By End-User

Contract Research Organizations

Medical Device Companies

Pharmaceutical and Biopharmaceutical Companies

Regional Analysis

The Healthcare Analytical Testing Services Market research examines and analyses every segment of the regional market in terms of its key regional market reach. The report covers import, export, development, demand, and consumption in great depth. The research covers in-depth the major international regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa.

Competitive Outlook

The research provided a succinct summary of the major contributors and market participants in order to respond to various questions from customers and readers. Customers will also learn about crucial factors in this study that, in terms of the supplier environment and present competition intensity, have a substantial impact on the development of the Healthcare Analytical Testing Services Market . The in-depth analysis of manufacturers, producers, distributors, and traders in the report is meant to assist key players with a variety of strategic choices and investment goals. Secondary and verified primary sources are used to analyse production data, percentage splits, market shares, product industry breakdowns, and growth rates for important competitors.

Key Objectives of Healthcare Analytical Testing Services Market Report

You can more clearly evaluate the potential of the major markets by having a thorough understanding of the specific market size and forecast information.

Conducting a detailed market analysis with an emphasis on market expansion and examining how current market developments have impacted customers' purchasing patterns.

About US

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Nucleotide Market Trends

Nutrigenomics Market Trends

Oncology Drugs Market Trends

Opioid Use Disorder Market Trends

Orthobiologics Market Trends

0 notes

sanpdr1994 · 2 years ago

Text

Poultry Diagnostics Market with business strategies and analysis to 2028

Future Market Insights in its new report has projected positive growth prospects for the Poultry Diagnostics Market for the assessment period between 2022 and 2028. High consumption of chicken on a global scale and increasingly strict food safety standards in developed countries will held aid growth.

Widespread outbreaks of infectious diseases such as avian influenza is a key factor driving the demand for diagnostic infrastructure in the poultry industry. Also, awareness campaigns by public and private bodies about avian diseases among poultry farmers is positively influencing the industry.

Furthermore, concerns over food security and investments by governments and international bodies towards the intensive farming sector will drive cultivation of poultry. This will also support the demand for poultry diagnostics in the long-term.

For More Information : https://www.futuremarketinsights.com/reports/poultry-diagnostics-market

Key Takeaways

ELISA tests are expected to continue holding major market share through 2030, owing to superior accuracy and cost efficiency. Diagnostics for avian influenza has been estimated to reflect higher market share on the back of widespread incidences in developing countries. Newer ailments such as mortality syndrome are expected to generate lucrative opportunities in terms of product development and interest from the veterinary sector. Virology services are expected to be a major contributor to the market owing to higher risk from viral infections for human consumers. South Asia & Pacific, will reflect fast growth, with poor hygiene standards in developing nations. North America will continue to hold larger market share, owing to superior infrastructure.

Insights on the Coronavirus Impact

As the covid-19 outbreak continues to wreak havoc on the global economy, the poultry diagnostics market is expected to also be adversely impacted during the crisis period. While chickens and other poultry birds are not at risk to the virus, the pandemic is likely to hurt consumption, logistics, and sales of birds. This can be largely attributed to strict regulations on the food service businesses.

These factors are expected to reduce chicken stocks in the poultry industry for the short term, which in turn will reduce the demand for diagnostic tools and infrastructure in the industry. The market is likely to recover strongly towards 2021, as demand for poultry products picks up. Strict food safety laws and concerns over other strains of coronavirus will aid market developments.

Market Competitiveness

Market leaders in the poultry diagnostic industry include but are not limited to Agrobiotek Internacional, Bioneer Corporation, Affinitech Ltd., Zoetis Inc., Biochek, Thermo Fisher Scientific, Bioingentech Biotechnologies Inc., Qiagen N.V., Bionote Inc., Megacor Diagnostik GmbH, and Idexx Laboratories Inc.

Market participants are increasingly focused on the product research with the aim of developing and launching improved testing tools for faster and accurate results. In addition, strategic industry collaborations and acquisitions are being used to build a foundation in a moderately competitive landscape.

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies Detailed insights of market segments and sub-segments for historical as well as forecast period A competitive analysis of prominent players and emerging players in the keyword market Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

#Poultry Diagnostics Market #Poultry Diagnostics Market Size #Poultry Diagnostics Market Growth

0 notes

saltytyphoonstarlight · 2 years ago

Text

Poultry Diagnostics Market

Poultry diagnostics market size is estimated to grow at an impressive CAGR of 10.5% from 2022 to 2028, and rise from a market valuation of US$ 495.2 Million in 2022 to US$ 1.1 Billion by 2028.

Key Takeaways

ELISA tests are expected to continue holding major market share through 2030, owing to superior accuracy and cost efficiency.

Diagnostics for avian influenza has been estimated to reflect higher market share on the back of widespread incidences in developing countries.

Newer ailments such as mortality syndrome are expected to generate lucrative opportunities in terms of product development and interest from the veterinary sector.

Virology services are expected to be a major contributor to the market owing to higher risk from viral infections for human consumers.

South Asia & Pacific, will reflect fast growth, with poor hygiene standards in developing nations. North America will continue to hold larger market share, owing to superior infrastructure.

Insights on the Coronavirus Impact

Competition Analysis:

Market leaders in the poultry diagnostic industry include but are not limited to

Agrobiotek Internacional

Affinitech Ltd.

Biochek

Bioingentech Biotechnologies Inc.

Bionote Inc.

Boehringer Ingelheim GmbH

GD Animal Health

Idexx Laboratories Inc.

IDVet

Megacor Diagnostik GmbH

Qiagen N.V.

Thermo Fisher Scientific

Zoetis Inc.

Bioneer Corporation

Poultry Diagnostics Market Segmentation:

By Test:

ELISA Test

PCR Test

By Disease:

Avian Salmonellosis

Avian Influenza

Newcastle Disease

Avian Mycoplasmosis

Avian Pasteurellosis

Infectious Bronchitis

Infectious Bursal Disease

Avian Encephalomyelitis

Avian Reovirus

Chicken Anemia

By Service:

Bacteriology

Virology

Parasitology

By Region:

North America

Europe

APAC

ROW

For More Information: https://www.futuremarketinsights.com/reports/poultry-diagnostics-market

0 notes

healthcareresearchboom · 3 years ago

Text

Biologics Safety Testing Market – Size, Value, Share, Research and Analysis 2026

The global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments. In addition, emerging markets and increasing biopharmaceutical outsourcing are expected to provide significant growth opportunities for players in the Biologics safety testing market.

Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144

The residual host-cell proteins and DNA detection tests segment accounted for the largest share of the Biologics Safety Testing market in 2020.

Based on test type, the biologics safety testing market is segmented into residual host-cell proteins and DNA detection tests, endotoxin tests, sterility tests, mycoplasma tests, bioburden tests, and virus safety tests. In 2020, the residual host-cell proteins and DNA detection tests segment accounted for the largest market share. The rising demand for residual HCP and DNA detection tests for recombinant proteins and increasing focus on the quality of drugs are the major factors driving the growth of this segment.

The monoclonal antibodies manufacturing segment accounted for the largest market share of the Biologics safety testing market in 2020.

Based on application, the biologics safety testing market is segmented into monoclonal antibodies manufacturing, vaccines manufacturing, blood and blood products manufacturing, cellular and gene therapy products manufacturing, and other applications. In 2020, the monoclonal antibodies manufacturing segment accounted for the largest market share. The large share of this segment can be attributed to the rising prevalence of diseases and increasing government initiatives for the development of monoclonal antibody drugs.

The Asia Pacific region is the fastest growing region of the Biologics safety testing market in 2020.

The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to the expansion of key market players in emerging Asia Pacific countries, increasing expenditure on life science research, and the increasing trend of pharmaceutical outsourcing to Asia Pacific countries.

Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins Scientific (Luxembourg). The key players in this market are focusing on strategic expansions, partnerships, and product launches and approvals to expand their presence in the market.

Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144

Don’t miss out on business opportunities in Biologics Safety Testing Market. Speak to our analyst and gain crucial industry insighs that will help your businessgrow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 [email protected]

#Biologics Safety Testing Market

0 notes

itssashasharma · 3 years ago

Text

Global Biologics Safety Testing Market worth $ 6.2 billion : Emerging markets offer lucrative opportunities

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global biologics safety testing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects.

According to the new market research report “Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products), Test Type (Endotoxin, Myoplasm, Sterility Test) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments. In addition, emerging markets and increasing biopharmaceutical outsourcing are expected to provide significant growth opportunities for players in the Biologics safety testing market. Browse in-depth TOC on “Biologics Safety Testing Market” 142 – Tables 42 – Figures 185 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144 The growth of the global biologics safety market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments. COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic. The World Health Organization (WHO) officially declared the outbreak of COVID-19 a pandemic. A mix of established pharmaceutical and biopharmaceutical companies, along with the players of the Biologics safety testing market, have stepped forward to contribute to worldwide research efforts by providing biologics safety testing for developing safety test kits and testing for treatments and vaccines manufacturing that target the infection caused by the novel Coronavirus. The residual host-cell proteins and DNA detection tests segment accounted for the largest share of the Biologics Safety Testing market in 2020. Based on test type, the market is segmented into residual host-cell proteins and DNA detection tests, endotoxin tests, sterility tests, mycoplasma tests, bioburden tests, and virus safety tests. In 2020, the residual host-cell proteins and DNA detection tests segment accounted for the largest market share. The rising demand for residual HCP and DNA detection tests for recombinant proteins and increasing focus on the quality of drugs are the major factors driving the growth of this segment. The monoclonal antibodies manufacturing segment accounted for the largest market share of the market in 2020. Based on application, the biologics safety testing market is segmented into monoclonal antibodies manufacturing, vaccines manufacturing, blood and blood products manufacturing, cellular and gene therapy products manufacturing, and other applications. In 2020, the monoclonal antibodies manufacturing segment accounted for the largest market share. The large share of this segment can be attributed to the rising prevalence of diseases and increasing government initiatives for the development of monoclonal antibody drugs. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144 The Asia Pacific region is the fastest-growing region of the Biologics safety testing market in 2020. The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to the expansion of key market players in emerging Asia Pacific countries, increasing expenditure on life science research, and the increasing trend of pharmaceutical outsourcing to Asia Pacific countries. Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), and Eurofins

Scientific (Luxembourg). The key players in this market are focusing on strategic expansions, partnerships, and product launches and approvals to expand their presence in the market. Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting Browse Related Reports: Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/mycoplasma-testing-market-136509856.html Pyrogen Testing Market by Product & Service (Assays, Kits, Reagents, Instruments, Services), Test Type (LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User (Pharmaceutical, Biotechnology, Medical Device), Region – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/pyrogen-testing-market-255266155.html About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected] Research Insight: https://www.marketsandmarkets.com/ResearchInsight/biologics-safety-testing-market.asp Visit Our Web Site: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/biologics-safety-testing.asp

#Biologics Safety Testing Market

0 notes

esglatestmarketnews · 3 years ago

Text

Healthcare Contract Research Organization Market Size, Outlook, Trend and Forecast Analysis Report 2021 to 2028

September 30, 2021: The global healthcare contract research organization market was prized by USD 39.6 billion in 2020. It is estimated to witness 6.6% CAGR from 2021 to 2028.

Drivers

The ending of the patent in healthcare division, rising funds for R&D plans, and inclination for sub contracting the actions because of price and time restriction, are the important factors expected to propel the market for healthcare CRO, during the near future.

The partnerships for contract research provide advanced services and hence government institutes have a preference for transferring projects to Contract Research Organizations (CROs), in this manner helping the expansion of the market.

Effect of Covid-19

Similar to other sectors the market for healthcare CRO has obviously got influenced, due to the global eruption of Covid-19 pandemic, clinical trials are suspended because the enrollment of the patients has happened to be strained and working places are closed.

The research for the Covid-19 treatments has increasing by a considerable pace. The global research group has begun spotting the medicinal treatment for Covid-19, by way of monitoring together the presented as well as fresh medicines, for their capability to lessen the indications and stop the duplication of the virus.

Request a Free Sample Copy of this Report @ https://www.millioninsights.com/industry-reports/healthcare-contract-research-organization-cro-market/request-sample

Type Insight

The clinical section held the major, 76.7% revenue share and led the healthcare contract research organization market, in 2020, on the basis of type. The share is credited to the demand for higher technologies, increasing number of biologics and the necessity for custom-made medication, along with orphan drugs. The issues like demand for contract research organizations to carry out clinical test, technical progression and globalization of clinical examinations, are additionally expected to propel the enlargement.

Owing to the reality that they are one of the major costly steps of a clinical trial, subcontracting of phase III clinical trials to healthcare contract research organizations produced the maximum revenue in 2020. Roughly 90.0% of the operating costs take place, at some stage in the clinical improvement of a medicine stems, from this phase.

The preclinical studies section is expected to observe the fast enlargement percentage of 8.3%, throughout the forecast period. Growth in the figure of preclinical tests concerning big molecules plus the rising necessity to limit the R&D expenditure is likely to add to the increasing demand for superior preclinical contract research organization, in this manner adding to the expansion of the market.

Service Insight

The clinical monitoring section held above 18.0% revenue share and dominated the healthcare CRO market, in 2020. Furthermore, it is expected to retain its place, during the forecast period. This may be credited to the rising figure of clinical trials as well as the necessity to check those revisions, which are generating additional demand for the services.

During the previous decade clinical research is being subcontracted to contract research organizations because of diverse causes, for example, technological proficiency along with the price efficiency. The initiation of instantaneous information attainment procedures and smart analytics are projected to enhance the monitoring of clinical information, within the healthcare division. Attainment of concurrent information linked with the toxicity and safety of the medicine facilitate before time recognition of test inaccuracy along with it makes possible appropriate rectifications like execution or revamping of the test, in this manner boosting the expansion of the section.

The regulatory/medical affairs division is expected to observe the highest, 11.1% enlargement speed during the forecast period. The sub-contracting for regulatory affairs is speedily increasing because of the medicines in pipeline, function of clinical trial, rise in R&D actions and listing of the product. The rising demand for doing more with less, to get endorsement for fresh products and preserve compliance is expected to maintain the expansion of the market.

Regional Insight

In 2020, Asia Pacific held major, 42.0% revenue share and led global healthcare contract research organization market. Furthermore, the state is projected to develop by a fast speed during the forecast period. This may be credited to the system of rules according to the expected standards, accessibility of assorted populations, greater occurrences of chronic circumstances, and effortless enrollment of the patients as well as withholding.

Moreover, positive support by the government is, furthermore, adding to the expansion of the market. Such as, the Central Drugs Standard Control Organization (CDSCO) prepared fresh regulations that are expected to decrease the necessary period for sanction to almost 30-60 days, as a result, pushing the expansion of the market.

As a result of the maximum number of trials carried out as well as sub contracted within the region, North America held the major share of the market, in 2020. Besides, increasing encouragements for R&D actions by the government by means of finances and donations to research organizations as well as the companies has pushed this local market.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/healthcare-contract-research-organization-cro-market

Companies

The healthcare contract research organizations are involved in joining forces to endorse their services on worldwide stage, along with presenting better services. To maintain the functioning of clinical trials during in the present pandemic situation, the market contestants are implementing the diverse models particularly virtual experimental testing. For example, PRA Health Sciences is presently carrying out, globally, more than 40 hybrid and virtual tests for their customers. It is toting up more than a million patients in above 30 nations.

Some of the companies for healthcare contract research organization market are:

• PRA Health Sciences

• Wuxi AppTec

• Pharmaron

• Medidata Solutions, Inc.

• Charles River Laboratories International, Inc.

• Pharmaceutical Product Development, LLC

• IQVIA Holdings Inc.

• CTI Clinical Trial & Consulting

• MEDPACE HOLDINGS, INC.

• GVK Biosciences Private Limited

• Syneos Health

• ICON, plc

• Parexel International Corporation

• Covance Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Million Insights has segmented the global healthcare contract research organization market report on the basis of type, service, and region:

Type Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Discovery

• Target Validation

• Lead Identification

• Lead Optimization

• Pre-clinical

• Clinical

• Phase I Trial Services

• Phase II Trial Services

• Phase III Trial Services

• Phase IV Trial Services

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: [email protected]

0 notes

blueweave01 · 3 years ago

Text

Global Process Analyzer Market Poised for Modest Growth: Projected to Grow at a CAGR of 3.4% by 2027

Due to the increasing demand from industries such as chemical, oil & gas, and others and stringent government regulations regarding equipment quality, global process analyzer market is increasing at a high CAGR....

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that global process analyzer market was worth USD 6.9 billion in 2020. According to the study, the market is estimated to grow at a CAGR of 3.4%, earning revenue of around USD 8.7 billion by the end of 2027. The market for process analyzers is flourishing because of the wide variety of applications it serves, such as generation & transmission, chemicals, etc. Analyzers are engineering instruments used for determining the physical properties of substances or chemical composition involved in manufacturing procedures. These tools also help preserve assets and detect chemical, physical, and molecular properties in samples. In order to analyze a product as it goes through processing, it is important to decide on its chemical composition, boiling point, freezing point, pressure, and color. Urbanization and quality regulations regarding consumer goods are also driving the growth of the global process analyzer market.

Use of Process Analyzer in Treating Waste Water Treatment Is Expected to Boost the Global Process Analyzer Market

Process analyzers are increasingly being used in water treatment, which is driving the market demand for them. With growing water pollution levels in water bodies and underwater sources, the demand for water treatment before consumption is emerging as a necessity because of the increasing prevalence of water-borne diseases. The governments of different countries have been issuing strict regulations regarding chemical process analyzers to ensure water safety. This is a primary factor fueling the growth of the global process analyzer market.

Growing Application of Process Analyzer Technology in Drug Testing Is Anticipated to Drive the Global Market

The growing application of process analyzer technology in drug testing is a major driving factor for the global process analyzer market. The FDA encourages the pharmaceutical industry to use the latest scientific advancements, such as process analyzer technology, to detect potential contamination and to monitor nutrients in real-time. This technology is also applied for fault-tolerant operations, ensuring high reliability in harsh industrial environments. Thus, stringent government regulations regarding drug safety are significantly propelling the growth of the global process analyzer market.

ProcessAnalyzersFind Their Biggest Market Share in the Pharmaceuticals Industry

Based on end-users, the global process analyzer market is segmented into oil & gas, petrochemicals, pharmaceuticals, water & wastewater, power, food &beverage, paper & pulp, metal & mining, cement& glass, and others. The pharmaceuticals industry holds the largest market share as it is a crucial step during the drug manufacturing process. Process analyzers are used to ensure the drug’s safety and quality and determine if it meets regulatory standards. The growing pharmaceutical industry will drive the process analyzer market in the global forecast period.

Request For Free Sample Report @ https://www.blueweaveconsulting.com/report/global-process-analyzer-market-bwc20194/report-sample

Global Process Analyzer Market - Regional Insights

Geographically, the global process analyzer market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Asia-Pacific is projected to witness the highest CAGR during the forecast period among these regions. The manufacturing industry in emerging economies, especially in India, and China, is expected to boost the process analyzers market over the projected period. Additionally, emerging economies hold great potential for growth in the process analyzer market due to the increased investment in research and development.

Impact of COVID-19 on Global Process Analyzer Market

The global process analyzer market was significantly impacted during the initial phase of the COVID-19 pandemic. Increasing Coronavirus cases and the subsequent lockdown to stem the spread of the virus disrupted the functioning of various end-user industries of the process analyzer market. This resulted in the reduced demand for process analyzers, incurring severe losses to the industry players. However, the market is estimated to recover soon in the post-COVID-19 period as the lockdown is lifted and the economic activities resume. Furthermore, the market growth of process analyzers is expected to be boosted by the increasing application of these instruments in the pharmaceutical industry due to the high prevalence of diseases during the quarantine period.

Competitive Landscape

The leading players in the global process analyzer market are ABB Ltd., AMETEK Process Instruments, Applied Analytics, Inc., Yokogawa Electric, Corporation, Endress+Hauser AG, Thermo Fisher Scientific, Inc., Emerson Electric Co., Siemens AG, Suez, Mettler-Toledo International Inc., Modcon Systems LTD., Labcompare., Advanced CAE Pte Ltd., Servomex, Sartorius AG, Honeywell., Schneider Electric, SUEZ, Hach, Modcon Systems LTD., Teledyne Technologies Incorporated, and other prominent players.

The global process analyzer market is highly fragmented, with the presence of various global and regional industry participants. The regional industry players have deeper penetration in the local market. The companies significantly focus on improving their offerings to gain a competitive edge over the market. Furthermore, the adoption of competitive strategies like partnerships, mergers, acquisitions, collaborations, etc., is also prominent in this market.

Don’t miss the business opportunity of the global process analyzer market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report’s in-depth analysis provides information about growth potential, upcoming trends, and the global process analyzer market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global process analyzer market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

0 notes

nitu5965 · 3 years ago

Text

Data as a Service Market Analysis, Segments, Key Players, Drivers, Trends, and Forecast 2017– 2027

Data as a Service Market Highlights:

Data as a service (DaaS) relies on the cloud to ensure data storage, data integration, data processing, and delivery of applications over a network. The accumulation of large volumes of data and the preference of cloud for storage of information has brought the service to the forefront. The global data as a service (DaaS) market report by Market Research Future (MRFR) contains an overview of the industry, its benefits in various industries, and its prospects for the period of 2018 to 2023 (forecast period). The impact of the virus on the market has been explored.

The Data as a Service Market is expected to grow at a CAGR of 39% and reach a size of USD 12 billion by the end of 2023.

The shift to cloud for building applications and scaling them at low costs is one of the primary drivers of the market. DaaS provides information to customers irrespective of geographical location or separation of provider and consumer. Companies have managed to maintain the integrity of their data and improve agility of workloads owing to dependence on analytics and management and storage of pertinent data.

Adoption of big data analytics and cloud services in enterprises for storage and maintenance of data can bode well for the market. Initiatives of Bring Your Own Devices (BYOD) and enterprise mobility can drive the market forward. The decision of enterprises of providing users control over their data on a cloud can reduce data access times and enhance data processing. The market faces challenges from cybersecurity issues and a paucity of skilled personnel for maintaining huge data volumes.

Request a Free Sample @ https://www.marketresearchfuture.com/sample_request/6057

Competition Outlook:

IBM Corporation, Oracle Corporation, Mastercard Advisors LLC, Microsoft Corporation, Fair Isaac Corporation, LexisNexis Corporation, Google Inc., LinkedIn Corporation, Salesforce.com, Inc., Facebook, Inc., Bloomberg Finance L.P., and Alibaba Group Holding Limited are major providers in the global DaaS market.

Segmentation:

· By deployment, the market is segmented into public cloud, private cloud, and hybrid cloud.

· By organization size, the market is segmented into small and medium enterprise and large enterprise.

· By end user, the market is segmented into IT & telecom, BFSI, retail, manufacturing, media & entertainment, transportation, healthcare, and others.

· By pricing model, the market is divided into volume-based pricing model and data type-based pricing model. Volume-based pricing model includes quantity based pricing and pay per use pricing.

· By solution, the market is segmented into data migration, data warehousing, disaster recovery and backup solution, test data management, and others.

· By professional services, the market is segmented into consulting, implementation & deployment, and support & maintenance.

Regional Analysis:

The geographical analysis of data as a service market is studied for North America, Europe, Asia Pacific (APAC), and Rest-of-the-World (RoW).

North America is expected to dominate the data as a service (DaaS) market during the forecast period. It features a significant amount of unstructured data gathering due to digital revolution across the commercial and industrial sectors. Moreover, the early adoption of cloud-based deployment services in North America has made it easier for the industrial verticals to opt big data analytics to re-structure business functions and strategies. This is evident with Streetlight Data raising funds to the tune of USD 15 million for using big data acquired through smartphones. The data is used in adhering to latest social distancing measures during the COVID-19 pandemic and the safety of passengers commuting through buses and other forms of public transport.

APAC is expected to grow at a significant pace during the forecast period. Due to increasing adoption of cloud-based services and data-centric strategies adopted by businesses in the Asia countries, the global data as a service (DaaS) market has ample scope in expanding. Initiatives of incentives for startups and commencement of digitization can bode well for the market in the coming years.

Table of Contents

1 Executive Summary

2 Scope of the Report

2.1 Market Definition

2.2 Scope of the Study

2.2.1 Research Objectives

2.2.2 Assumptions & Limitations

2.3 Markets Structure

3 Market Research Methodology

3.1 Research Process

3.2 Secondary Research

3.3 Primary Research

3.4 Forecast Model

Continued…

Access Report Details @ https://www.marketresearchfuture.com/reports/data-as-a-service-daas-market-6057

List of Tables

Table1 World Population by Major Regions (2018 To 2023)

Table2 Global Data as a Service Market: By Country, 2018-2023

Table3 North America Data as a Service Market: By Country, 2018-2023

Continued…

List of Figures

Figure 1 Global Data as a Service Market Segmentation

Figure 2 Forecast Methodology

Figure 3 Porter’s Five Forces Analysis of Global Data as a Service Market

Continued…

About Market Research Future:

Market Research Future (MRFR) is a global market research firm that takes great pleasure in its services, providing a detailed and reliable study of diverse industries and consumers worldwide. MRFR's methodology integrates proprietary information with different data sources to provide the client with a comprehensive understanding of the current key trends, upcoming events, and the steps to be taken based on those aspects.

Our rapidly expanding market research company is assisted by a competent team of research analysts who provide useful analytics and data on technological and economic developments. Our deemed analysts make industrial visits and collect valuable information from influential market players. Our main goal is to keep our clients informed of new opportunities and challenges in various markets. We offer step-by-step assistance to our valued clients through strategic and consulting services to reach managerial and actionable decisions..

Contact:

Market Research Future

Office No. 524/528, Amanora Chambers

Magarpatta Road, Hadapsar

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

#Data as a Service Market Data as a Service Market Data as a Service Market Forecast Data as a Service Market Trends Data as a Service Market

0 notes

blueweave · 3 years ago

Text

Global Automated Optical Inspection (AOI) System Market Gaining Momentum: Market Growing at the CAGR of 10.91% during the Forecast Period

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global automated optical inspection (AOI) system market was worth USD 750.3 million in the year 2020. The study also states that the market is estimated to grow at the CAGR of 10.91%, earning revenue of around USD 1705.9 million by the end of 2027.

The demand for high-performance electronic components for critical safety systems of vehicles, like advanced driver assistance systems (ADAS), airbags, and braking systems, has boosted the global automated optical inspection (AOI) system market. Moreover, the implementation of wireless communication technologies like M2M and connected vehicles has resulted in a surge in the adoption of electronics components in automobiles.

Escalating Demand for Optical Inspection (AOI) System in Automotive Electronics will Flourish the Market

The automotive industry is thriving at a very rapid rate due to technological advancements and the increasing disposable income of the masses. These are the primary factors driving the growth of the automated optical inspection (AOI) system market. Furthermore, the growing demand for inspection to assure the safety of vehicles equipped with advanced driver assistance systems, airbags, brake systems, and so on is propelling the market. Also, as automotive manufacturers strive to ensure the quality of their final products, the need for high-quality electrical components has increased dramatically. Ensuring the quality and safety of the vehicle is projected to pull significant demand for the AOI systems in the forecast period.

Escalating Demand for2D AOI System Type Will Boost the Overall Automated Optical Inspection (AOI) System Market During the Forecast Period

There are two types of automated optical inspection systems available in the automated optical inspection (AOI) system market, i.e., 2D AOI systems and 3D AOI systems. 2D AOI systems have a very high demand in the automated optical inspection (AOI) system market owing to lower prices and affordability, mainly among electronics manufacturers. The 2D AOI system offers various advantages, including cost-effectiveness, the ability to inspect surface mount technology, high-speed inspection, and color inspection capabilities. However, 3D AOI systems are projected to grow at a high CAGR during the foreseeable future due to their capability of inspecting co-planarity issues in components, detecting lifted leads, and reducing false call rates. These factors are contributing to the growth of the 3D automated optical inspection (AOI) system market.

Request For Free Sample Report @ https://www.blueweaveconsulting.com/report/global-automated-optical-inspection-(aoi)-system-market-bwc19247/report-sample

Global Automated Optical Inspection (AOI) System Market - By Application

Based on application, the global automated optical inspection (AOI) system market is bifurcated into printing, selective soldering, reflow soldering, wave soldering, and automation. The wave soldering segment dominates the application segment due to its widespread use in large production volumes, allowing for the manufacturing of numerous circuit boards in a short period. Wave soldering is a large-scale soldering procedure by which electronic components are soldered to a PCB to create an electronic assembly. The AOI systems identify the presence of any contamination or debris, as well as filled or missing holes inside the circuit boards, assisting in the prevention of future problems with electronic products.

APAC is Dominating Overall Automated Optical Inspection (AOI) System Market During the Forecast Period

Geographically, the global automated optical inspection (AOI) system market has been grouped into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The Asia Pacific is the leading region in the overall market followed by North America due to the high penetration of several electronic component and device manufacturing companies in the region. The presence of several vehicle manufacturers in China is also responsible for the increased usage of these machines. Additionally, favorable government policies and low production prices create tremendous growth opportunities for multinational and start-up electronics firms in China.

The North American automated optical inspection system market also accounts for a substantial market share because of significant technological breakthroughs across all manufacturing sectors, as well as the availability of numerous safety and compulsory inspection regulations for machinery production.

Impact of Covid-19 on the Global Automated Optical Inspection (AOI) System Market

The COVID-19 pandemic has wreaked havoc on the global automated optical inspection (AOI) system industry. Electronic and vehicle manufacturers are the major consumers of AOI systems. However, soon after the COVID-19 breakout, governments in some nations were forced to enforce a nationwide lockdown. Consequently, all the manufacturing and production operations of all non-essential goods like circuit boards, mobile phones, automobile parts, etc., were temporarily barred. The use and demand for AOI systems plummeted as a result of this. The market was severely harmed also because the virus affected two of the world's largest producers, China and India. Nevertheless, in the post-COVID-19 phase, the automated optical inspection (AOI) system market is projected to pick up again.

Global Automated Optical Inspection (AOI) System Market: Competitive Landscape

Companies such as KOH Young, Mirtec, Omron, Test Research, Inc. (TRI), Viscom, Camtek, Cyberoptics, Daiichi Jitsugyo (DJK), Nordson, Orbotech, Goepel Electronic, Marantz Electronics, Machine Vision Products, Saki, VI Technology, AOI Systems Ltd., Chroma Ate Inc., and Pemtron are the leading players in the global automated optical inspection (AOI) system market. The market is very dense and the competition is very stiff as the industry players are continually focusing on establishing more and more manufacturing plants to expand their consumer base. They are also working on product developments and launches to expand their product portfolio.

Don’t miss the business opportunity of the global automated optical inspection (AOI) system market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report’s in-depth analysis provides information about growth potential, upcoming trends, and statistics of the global automated optical inspection (AOI) system market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global automated optical inspection (AOI) system market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.

#Global Automated Optical Inspection (AOI) System Market #Automated Optical Inspection (AOI) System Market #AOI System Market

0 notes

marketreportsupdates · 3 years ago

Text

Emergency Ventilator Market Global Growth, Global Survey, Analysis, Share, Company Profiles and Forecast by 2028

Increasing investment in healthcare and improving healthcare infrastructure are key factors driving market growth

The global emergency ventilator market size is expected to reach USD 1,616.13 Million in 2028 registering a CAGR of 16.2% over the forecast period, according to a latest report by Reports and Data. Major factors driving market revenue growth are increasing investment in healthcare, improving healthcare infrastructure and increasing public awareness about health and safety. Ventilators are essentially machines that help patients breath when they are not able to breath of their own. Emergency ventilators are compact ventilators suitable for emergency and disaster relief situations, deployed in ambulances, or ambulatory clinics, public areas and also for intra-hospital and inter-â€‹hospital purposes.

The COVID-19 pandemic has become one of the chief driving forces for the emergency ventilator market. With the rapid spread of the virus across the world, a global shortage of ventilators has emerged, necessitating numerous efforts. While industry focuses on producing medical-grade equipment, a number of low-cost, less complex emergency ventilators have been produced, primarily through academic and open-source channels, with the hopes of filling any temporary gaps until medical-grade ventilators become available. Many medium and lower-income countries are in desperate need of ventilators because they lack adequate equipment and their critical care systems are still in their infancy, which has generated a significant opportunity for the emergency ventilator industry.

A flurry of activities centred on developing low-cost emergency ventilators that can be deployed quickly. Utilisation of generic off-the-shelf parts, readily available materials, and inexpensive fabrication procedures are significant features of these devices. These devices only have a fraction of the capability of traditional ventilators and would only be justified in emergency situations if standard medical equipment is unavailable or prohibitively expensive.

The negative effects of invasive emergency ventilators and the rising cases of infection with the use of unsterilized ventilators are expected to restrain market growth to a certain extent over the forecast period.

Get a sample copy of the global Emergency Ventilator market report @ https://www.reportsanddata.com/sample-enquiry-form/547

Some Key Highlights in the Report:

On the basis of mode, the market is segmented as volume-controlled ventilation modes, pressure-controlled ventilation modes, assisted ventilation mode.

On the basis of type, the market is segmented as adult, pediatric and neonatal. In 2020, the adult segment accounted for the largest market revenue share.

On the basis of interface, the market is segmented as invasive and non-invasive. While the invasive interface is riskier to the patient than non-invasive interface, many critical patients need invasive ventilators to survive.

On the basis of end use, the market is segmented as hospital, ambulance, ambulator services and home use. In 2020, the hospital end use segment accounted for the largest market revenue share.

North America emergency ventilator market is expected to account for largest revenue share over the forecast period due to technological innovation and advances in healthcare infrastructure

Revenue from the Asia Pacific emergency ventilator market is expected to expand at a significantly high CAGR due to government initiatives for increasing expenditure in the healthcare sector and increasing severity of COVID-19 situation in countries like India where emergency ventilators are in high demand.

Prominent players in the market are: Koninklijke Philips N.V., ResMed, Medtronic plc, Becton, Dickinson and Company, Getinge, Drägerwerk AG, Smiths Group plc, Hamilton Medical, GE Healthcare, Fisher & Paykel, Air Liquide, Zoll Medical Corporation, Allied Healthcare Products, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Schiller.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/547

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global emergency ventilator market on the basis of mode, type, interface, end use, and region:

Mode Outlook (Revenue, USD Million; 2018 – 2028)

Volume-Controlled Ventilation

Pressure-Controlled Ventilation

Assisted Ventilation

Type Outlook (Revenue, USD Million; 2018 – 2028)

Adult

Pediatric

Neonatal

Interface Outlook (Revenue, USD Million; 2018 – 2028)

Invasive

Non-invasive

End Use Outlook (Revenue, USD Million; 2018 – 2028)

Hospital

Ambulance

Ambulatory Service

Home use

Regional Outlook (Revenue, USD Million; 2018 – 2028)

U.S.

Canada

Mexico

Germany

U.K.

France

Italy

Spain

Rest of Europe

China

India

Japan

South Korea

Rest of Asia Pacific

Brazil

Rest of Latin America

Saudi Arabia

U.A.E.

South Africa

Rest of Middle East & Africa

Major Highlights of the Emergency Ventilator Market Report:

The Emergency Ventilator market analysis report offers an in-depth study of the potential market growth opportunities and challenges.

The report dives deeper into the market and explains the dynamic factors bolstering market growth.

The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.

The report analyzes the Emergency Ventilator market presence across major regions of the world.

It determines the production & consumption capacities and demand & supply dynamics of each regional market.

The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.

It provides company overview and SWOT analysis of each of the market players.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/547

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

Read More Reports:-

Aesthetic Medicine Market @ https://www.google.me/url?q=https://www.reportsanddata.com/report-detail/aesthetic-medicine-market

Antidiabetics Market @ https://www.google.rw/url?q=https://www.reportsanddata.com/report-detail/antidiabetics-market

Anxiety Disorder and Depression Treatment Market @ https://www.google.cf/url?q=https://www.reportsanddata.com/report-detail/anxiety-disorder-and-depression-treatment-market

Biological Safety Testing Market @ https://www.google.tg/url?q=https://www.reportsanddata.com/report-detail/biological-safety-testing-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

0 notes

amitshinde7793 · 3 years ago

Text

COVID-19 Impact on Medical Face Shield in Healthcare Industry | Data Bridge Market Research

COVID-19 Impact on Medical Face Shield in Healthcare Industry

In Wuhan, China, the first case of the COVID-19 pandemic was discovered. The pandemic has had a global effect with huge ramifications for economies and industries all over the world. COVID-19 spread in unparalleled ways across the world due to its highly infectious and contagious nature and the absence of vaccine. As a result, doctors around the world are still struggling with the biggest medical problem of the twenty-first century. Though the virus roots can be traced back to Asia, the pandemic has devastated several European countries as well as the United States. The virus has spread around the world from North America to Europe to Asia, the Middle East and Africa to South America. The World Health Organization (WHO) has declared COVID-19 as a pandemic due to its rapid spread across the world. Following the pandemic's announcement, many nations including the United States, Germany, India and China had declared full lockdowns in order to stem the spread of the disease. COVID-19's infectious existence has increased the demand for medical face shields among people in variety of professions. According to World Health Organization (WHO) study dated July 28th, 2020, 16,341,920 cases of coronavirus have been identified worldwide with 650,805 patients dying as a result of the virus. The COVID-19 outbreak is wreaking havoc on the healthcare industry especially the medical face shield sector.

IMPACT ON DEMAND

The COVID-19 pandemic has catapulted the medical face shield industry from obscurity to prominence. Surgical face masks have proven to be effective in preventing many deadly epidemics in the form of infectious diseases such as the flu, SARS and Zika virus long before the pandemic. The pandemic of COVID-19 has increased the use of medical face shields in variety of settings. Several firms in other sectors are keen to join and some have already joined the medical face shield landscape in order to raise sales by fulfilling the immediate need for protective equipment in the event of a virus outbreak.

For instance,

· In May 2020, Ripclear, a maker of specialized protective films for sports eyewear, released V2 Shield, a product intended to protect personnel fighting the COVID-19 outbreak such as nurses, police officers, emergency medical technicians and other front-line staff.

· In May 2020, Bauer, a leading hockey equipment maker has retooled its production to produce medical face shields for healthcare staff and people who are at risk due to the COVID-19 pandemic.

· In April 2020, Mahindra retooled its Detroit manufacturing facility to produce medical personal security devices such as medical face masks for frontline healthcare staff and infected people.

· In March 2020, ISAAC BUDMEN INDUSTRIES LLC, a 3D printer manufacturer has diverted its 3D printing operations to the production of medical face shields in order to meet the rising demand for personal protective equipment (PPE) as a result of the COVID-19 pandemic.

The Center for Disease Control (CDC) and other organizations such as Infectious Diseases Society of America (IDSA) has recommended the use of personal protective equipment (PPE) which includes face shield and face masks. Since the efficacy of safety equipment improves when both face masks and face guards are worn, they have been widely embraced by people all over the world. Face masks, on the other hand, are thought to be more effective in preventing the spread of respiratory viruses as SARS-CoV-2 by preventing droplets and eye spread. Many experimental tests have shown that using a medical face shield in conjunction with a face mask has a high level of efficacy. As a result, the main market players could see a major increase in demand for medical face shields.

Medical face shields are made of variety of materials including polycarbonate, propionate and cellulose acetate among others but polycarbonate-based medical face shields are in high demand. Furthermore, as opposed to reusable face shields, the fear of contamination has boosted the market for disposable medical face shields. Since the Asia-Pacific region has been the epicenter of the COVID-19 pandemic, the medical face shield market in this region has grown at the fastest pace.

The government of various regions has placed stringent sanctions on citizens who breach safety laws by not covering their faces which has resulted in an increase in demand for medical face shields. This has increased the demand for and use of medical face shields by employees in industries such as chemical, building, oil and gas, pharmaceutical and manufacturing to avoid fatal workplace accidents and injuries. The government of various regions has imposed harsh penalties on people who violate safety laws by not wearing face shields, resulting in a surge in demand for medical face shields. Employees in industries such as chemical, construction, oil and gas, pharmaceutical and manufacturing have increased their demand for and use of medical face shields to prevent fatal occupational accidents and injuries.

Medical face shields are expected to increase in popularity due to their numerous advantages and applications in various industries as well as their ability to provide complete face protection and properties such as reusability, ease of washing and no fear of raw material shortages.

IMPACT ON SUPPLY

The COVID-19 situation has caused supply chains to be disrupted around the board. The rapid advent of COVID-19 and its subsequent effect on trade and goods transport has resulted in the shutdown of large portions of the global economy, causing supply chains to be disrupted due to lack of supplies and workers and manufacturing to slow or stop. Several firms, on the other hand, are retooling for priority manufacturing to manufacture critical medical supplies and equipment including ventilators, face masks and medical face shields. The majority of companies have retooled are in the printing, upholstery and sewing sectors among others. These companies have already used acetate sheets in 3D printing, foam in upholstery and elastic ribbon in sewing to create medical face shields. As a result, different regions have been able to sustain their stock of emergency medical face shields.

Due to trade barriers, there is no alternative but to manufacture critical medical devices in the United States. As the demand grows during the pandemic, counterfeiting and price gouging of imported products rise with it.

The government, several businesses and research institutes are taking numerous initiatives to meet the growing demand of people all over the world.

For instance,

· In March 2020, The Massachusetts Institute of Technology's (MIT) mechanical engineering department has developed a new methodology for mass-producing medical face shields in order to satisfy the high demand for disposable face shields by healthcare professionals during the COVID-19 pandemic.

KEY INITIATIVES BY THE MARKET PLAYERS DURING COVID-19

· In June 2020, 3M will change their emphasis and manufacturing lines for the development of medical face shields to meet the ever-increasing demand of healthcare professionals in order to accommodate the demand for medical face shields in the United States.

· In April 2020, KCWW, a major maker of medicinal solutions for hygiene and more has announced a donation of USD 8.00 million to aid COVID-19 relief efforts. This donation made during a crucial phase of the COVID-19 pandemic strengthens the company's business reputation.

· In March 2020, in order to produce respirators, ventilators and face masks, Ford Motor Company partnered with 3M and GENERAL ELECTRIC COMPANY. This collaboration between the companies would help satisfy people's need for medical face shields during the COVID-19 pandemic.

· In March 2020, Dimensional Innovations teamed up with InStore Design Display of North Kansas City and the University of Kansas' Center for Design Research to produce medical face shields to satisfy the need for medical safety devices.

CONCLUSION

The novel COVID-19 virus is predicted to have a long-term effect across all industrial sectors. The COVID-19 epidemic caused people to be perplexed about the virus and how to treat it. The virus is not only a threat to human health but it has also caused economic hardship and extreme emotional distress. It triggered a chain reaction resulting in the introduction of a new generation of criteria and needs that were previously unmet. Health face shields are one of the requirements. Previously, surgical face masks were only used in few medical practices and businesses that used toxic chemicals among other things. However, due to the extremely infectious nature of the virus and its ease of transmission through droplets or even fomites, the demand for medical face shields has increased in the industry.

Because of the rising prevalence of these infectious diseases, a robust healthcare network and appropriate emergency medical services are needed (EMS). This has resulted in increased investment on medical care all over the world. The extremely infectious aspect of the disease has necessitated the use of personal protective equipment to prevent healthcare staff from being infected. In particular, personnel performing medical care during the lockout which is being introduced in different countries to deter the spread of COVID-19 are expected to wear surgical face masks and face shields. These trends are propelling the medical face shield market forward.

Since the medical face shield market's growth will be heavily dependent on therapeutic approaches to combat COVID-19, the strategy is likely to remain preventive even after the vaccine becomes effective. Customizable face shields can become a possibility in general, particularly when children return to school. Face shields and face masks can continue to be popular until vaccines are widely available. Nonetheless, the long-term demand picture is stable as people are more likely to take precautionary measures.

Despite the possibility of a cure or vaccine on the horizon, the pandemic is expected to last for a long time. As a result, the use of surgical masks and face shields will become more widespread boosting the production and growth of the medical face shield industry.

#Medical Face Shield #Medical Face Shield Market #Medical Face Shield Market Analysis #Medical Face Shield Market Analysis in Developed Countries #Medical Face Shield Market by Application #Medical Face Shield Market by Type #Medical Face Shield Market Development #Medical Face Shield Market Forcast #Medical Face Shield Market Future Innovation

0 notes

itssashasharma · 3 years ago

Text

Global Biologics Safety Testing Market worth $ 6.2 billion by 2026 : Emerging markets offer lucrative opportunities

The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments. In addition, emerging markets and increasing biopharmaceutical outsourcing are expected to provide significant growth opportunities for players in the Biologics safety testing market.

Browse in-depth TOC on “Biologics Safety Testing Market”

142 – Tables

42 – Figures

185 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144

The growth of the global biologics safety market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments.

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic. The World Health Organization (WHO) officially declared the outbreak of COVID-19 a pandemic. A mix of established pharmaceutical and biopharmaceutical companies, along with the players of the Biologics safety testing market, have stepped forward to contribute to worldwide research efforts by providing biologics safety testing for developing safety test kits and testing for treatments and vaccines manufacturing that target the infection caused by the novel Coronavirus.

The residual host-cell proteins and DNA detection tests segment accounted for the largest share of the Biologics Safety Testing market in 2020.

Based on test type, the market is segmented into residual host-cell proteins and DNA detection tests, endotoxin tests, sterility tests, mycoplasma tests, bioburden tests, and virus safety tests. In 2020, the residual host-cell proteins and DNA detection tests segment accounted for the largest market share. The rising demand for residual HCP and DNA detection tests for recombinant proteins and increasing focus on the quality of drugs are the major factors driving the growth of this segment.

The monoclonal antibodies manufacturing segment accounted for the largest market share of the market in 2020.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144

The Asia Pacific region is the fastest-growing region of the Biologics safety testing market in 2020.

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Browse Related Reports:

Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/mycoplasma-testing-market-136509856.html

Pyrogen Testing Market by Product & Service (Assays, Kits, Reagents, Instruments, Services), Test Type (LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User (Pharmaceutical, Biotechnology, Medical Device), Region – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/pyrogen-testing-market-255266155.html

About MarketsandMarkets™

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/biologics-safety-testing-market.asp

Visit Our Web Site: https://www.marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/biologics-safety-testing.asp

0 notes

rajyog7493 · 3 years ago

Text

Impact of COVID-19 on In-Vitro Diagnostics in the Healthcare Industry

COVID-19 Impact on In-Vitro Diagnostics in the Healthcare Industry

The coronavirus (COVID-19) pandemic is having a dramatic impact on the in-vitro diagnostics (IVD) including technologies such as PCR, NGS, ELISA, clinical chemistry, rapid-tests, hematology, hemostasis, urinalysis, microbiology testing, and others. Currently, in-vitro diagnostic is the only diagnosis used by the healthcare professionals in order to detect the spread of corona virus across the globe. The virus has spread across all regions ranging from North America, Europe, Asia-Pacific, Middle East and Africa up to South America. The COVID- 19 has been declared as a pandemic by WHO due to its increased spread across the globe. After the declaration of the pandemic, various countries announced the complete lockdown such as the U.S., Germany, India and China among more in order to decrease its spread. The lockdown of countries aids in surging of use of diagnostic kits in order to screen patients suffering from coronavirus. According to the situation, the report of 4th June 2020 by WHO stated 6,416,828 cases of corona has been reported globally and 382,867 patients are dead due to the coronavirus.

IMPACT ON DEMAND

Exponential rise in cases of corona virus across the globe is increasing the demand of in-vitro diagnostic kits. The factors responsible for the rise in demand of IVD includes increased market demand for PCR, NGS, serology-based rapid-test products, a supportive regulatory environment for product development and marketing along with sharp increase in target patient population. Due to these factors, various market players have been prompted to improve and strengthen their current production and distribution capabilities and to focus on upgradation and marketing of their product.

A RT-PCR based assay is the common method used to diagnose patients with COVID-19. The pandemic has led to significant rise in demands for reagents used in RT-PCR in the recent months, leading to shortages in reagents required to perform the key steps in the testing process such as RNA extraction kits.

Manufacturers of in-vitro diagnosis (IVD) have taken huge initiatives to increase patient access to diagnostic testing for coronavirus in hospitals, laboratories, and other test sites across globe to guide patient care and protect public health.

The companies listed below developed IVDs that gained Emergency Use Authorization from the U.S. FDA:

Molecular Diagnostic Tests for Detection of COVID-19

· Abbott : Abbott RealTime Sars-CoV-2 assay; ID NOW COVID-19; Alinity m SARS-CoV-2 assay

· altona Diagnostics GmbH : RealStar SARS-CoV02 RT-PCR Kits U.S.

· Rhenonix : Rheonix COVID-19 MDx Assay

· F. Hoffmann-La Roche Ltd : Cobas SARS-CoV-2

· Shengxiang Biotechnology Co., Ltd. : Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing)

· ScienCell Research Laboratories, Inc. : ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit

· SEASUNBIOMATERIALS : U-TOP COVID-19 Detection Kit; AQ-TOP COVID-19 Rapid Detection Kit

· Seegene Inc. : Allplex 2019-nCoV Assay

· Applied DNA Sciences : Linea COVID-19 Assay Kit

· AtilaBiosystems : iAMP COVID-19 Detection Kit

· BD : BioGX SARS-CoV-2 Reagents for BD MAX System; BD SARS-CoV-2 Reagents for BD MAX System

· Primerdesign Ltd : COVID-19 genesig Real-Time PCR assay

· QIAGEN : QIAstat-Dx Respiratory SARS-CoV-2 Panel

· Quidel : Lyra SARS-CoV-2 Assay; Lyra Direct SARS-CoV-2 Assay

· SD Biosensor, INC. : STANDARD M nCoV Real-Time Detection Kit

· Sherlock BioSciences : Sherlock CRISPR SARS-Cov-2 Kit

· SolGent Co., Ltd.. : DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit

· Thermo Fisher Scientific Inc. : TaqPath COVID-19 Combo Kit

· Trax Management Services Inc. : PhoenixDx 2019-CoV

· Zymo Research : Quick SARS-CoV-2rRT-PCR Kit

· BGI : Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV

· Biocore company : BioCore 2019-nCoV Real Time PCR Kit

· BioFire Defense : Bio Fire COVID-19 Test

· BioFire Diagnostics : BioFire Respiratory Panel 2.1 (RP2.1)

· bioMérieux SA : SARS-COV-2 R-GENE

· Bio-Rad Laboratories Inc. : Bio-Rad SARS-CoV-2 ddPCR Test

· Cepheid : Xpert Xpress Sars-CoV-2

· Co-Diagnostics, Inc : Logix Smart Coronavirus Disease 2019 (COVID-19) Kit

· DiaCarta : QuantiVirus SARS-CoV-2 Test Kit

· DiaSorin Molecular LLC : SimplexaCOVID-19 Direct Kit

· SpectronRx : Hymon SARS-CoV-2 Test Kit

· Fast Track Diagnostics Luxembourg S.à r.l. : FTD SARS-CoV-2

· Fosun Pharma USA : Fosun COVID-19 RT-PCR Detection Kit

· GeneMatrix, LLC : NeoPlex COVID-19 Detection Kit

· GenMark Diagnostics, Inc. : ePlex SARS-CoV-2 Test

· GenoSensor Corporation : GS COVID-19 RT-PCR KIT

· Gnomegen LLC : Gnomegen COVID-19 RT-Digital PCR Detection Kit; Gnomegen COVID-19-RT-qPCR Detection Kit

· Hologic Inc. : Panther Fusion SARS-CoV-2 Test; Aptima SARS-CoV-2 assay

· InBios International, Inc. USA : Smart Detect SARS-CoV-2 rRT-PCR Kit

· LABGENOMICS. : LabGun COVID-19 RT-PCR Kit

· Luminex Corporation : NxTAG CoV Extended Panel Assay; ARIES SARS-CoV-2 Assay

· Maccura Biotechnology Co. : SARS-Cov-2 Fluorescent PCR Kit

· Mesa Biotech : Accula SARS-Cov-2 Test

· NeuMoDx Molecular : NeuMoDx SARS-CoV-2 Assay

· IDEXX Laboratories, Inc. : OPTI SARS-CoV-2 RT PCR Test

· OSANG Healthcare : GeneFinder COVID-19 Plus RealAmp Kit

· PerkinElmer Inc. : Coronavirus Nucleic Acid Detection Kit

Serology Tests or Blood Based Test for Detection of COVID-19

· Abbott : SARS-CoV-2 IgG assay

· Autobio Diagnostics Co. : Anti-SARS-CoV-2 Rapid Test

· Bio-Rad Laboratories, Inc. : Platelia SARS-CoV-2 Total Ab Assay

· Cellex : qSARS-CoV-2 IgG/IgM Rapid Test

· Chembio Diagnostic Systems, Inc. : DPP COVID-19 IgM/IgG System

· DiaSorin : LIAISON SARS-CoV-2 S1/S2 IgG

· EUROIMMUN US, Inc. : Anti-SARS-CoV-2 ELISA (IgG)

· Healgen Scientific, LLC : COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma)

· Ortho Clinical Diagnostics : VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack; VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack

· F. Hoffmann-La Roche Ltd : Elecsys Anti-SARS-CoV-2

· Siemens : ADVIA Centaur SARS-CoV-2 Total (COV2T); Atellica IM SARS-CoV-2 Total (COV2T)

The EUL procedure was developed to accelerate the availability of the required IVDs in emergency situations in public health. It was aimed to aid interested procurement agencies and member states in the appropriateness of using a specific IVD, based on a limited set of data available on quality, safety and performance.

The IVDs eligible to be submitted for EUL includes -

· Assays for the detection of SARS-CoV-2 nucleic acid

· Rapid diagnostic tests for the detection of IgM/IgG to SARS-CoV-2

For instance,

· In May 2020, Thermo Fisher Scientific Inc.’s Applied Biosystems TaqPath COVID-19 Combo Kit was initially granted EUA on March 13th and subsequently expanded on April 20th, is designed to deliver results of the test within four hours of a sample collection and processed by a CLIA high-complexity laboratory.

In the first half of 2020 (H1), the U.S. is anticipated to account for the largest share of in-vitro diagnostics industry followed by Europe. This owes primarily to the ongoing marketing of innovative diagnostic products associated with ongoing advances in the field of gene & immunoassay based products, the latest discovery of genetic biomarkers and their clinical significance in immunoassay testing, favorable government policies and their emphasis on the development of new products, and the significant expansion of target population.

Key manufacturers of IVD kits in the U.S. include Abbott, Thermo Fisher Scientific Inc. and F. Hoffmann-La Roche Ltd among others.

IMPACT ON SUPPLY

Due to the rising demand for in-vitro diagnostic (IVD) kits, it has been observed that falsified medical products are flourishing in the market. These fake testing kits render the life of a patient at stake. WHO has received several reports concerning falsified in-vitro diagnostics (IVDs) and laboratory reagents for SARS-CoV-2 detection. Further, the misuse, stockpiling, and price gouging leads to severe supply chain disruptions. This has increased the risk for healthcare facilities with limited access to IVD kits during the care of COVID-19 patients. China being the epicenter of the pandemic became the key spot to disrupt the supply of goods.

STRATEGIC DECISIONS BY MANUFACTURERS

With the declining trend and inefficient management of the supply chain, the government and manufacturers are taking initiatives to effectively manage the supply of in-vitro diagnostic kits and make appropriate use of those products in healthcare settings. The capacity to expand reagent and IVD kit production are limited, resulting in unmet needs.

Collaboration, agreements, strategic initiatives by market players in IVD diagnostic markets such as Abbott, Bio-Rad Laboratories, Inc., DiaCarta, QIAGEN among more will help them expand their product portfolio thereby leading to market expansion. This, in turn, will help increase demand for its product in the market thus increasing future sales.

For instance,

· In May 2020, Thermo Fisher Scientific Inc. collaborated with WuXi Diagnostics and Mayo Clinic in order to develop a complete antibodies test for detection of corona virus thereby expanding its response for COVID-19.

Initiative for Meeting Supply Gap by Abbott:

· In May 2020, Abbott has shipped nearly 2.5 million of their rapid ID NOW tests to all 50 states, including Washington DC, Puerto Rico and the Pacific Islands.

· It manufactures 50,000 tests per day and planning to further increase the manufacturing capacity of ID NOW to 2 million tests a month by June.

CONCLUSION

It has been observed through the vast spread and rising trends of coronavirus cases each passing day that the novel coronavirus or COVID-19 is expected to leave a significant impact on every aspect of life or market. The risk pose by the infectious disease is not restricted to health but the dwindling economy also. The healthcare domain is under huge pressure to deal with the unimaginably big situation of COVID-19. Moreover, the surge in patients with this infectious disease anticipates in driving the demand for in-vitro diagnostics (IVD) in the market.

The market of in-vitro diagnostic has experienced growth owing to increased demand for nucleic acid amplification tests per day along with the reagents used to perform these tests. The advancement in technology, favorable support provided by the government, and ease in regulations are also aiding in its growth across the globe. The strategic initiatives are taken by the key market players such as Thermo Fischer Scientific Inc., and others to develop novel COVID testing kits to expand their market is fueling the market growth. Hence, it can be concluded that the in-vitro diagnostics (IVD) market is expected to show healthy growth and substantial future demand for the rapid diagnostic testing kits due to the ever-increasing number of patients suffering from coronavirus.

#In-Vitro Diagnostics Market #In-Vitro Diagnostics Market Analysis #In-Vitro Diagnostics Market Analysis in Developed Countries #In-Vitro Diagnostics Market by Type #In-Vitro Diagnostics Market Forcast #In-Vitro Diagnostics Market Future Innovation

0 notes